READDI
READDI is retooling the drug discovery and development process to rapidly develop new antiviral drug solutions for the future.
READDI
Social Links:
Industry:
Biotechnology
Founded:
2020-01-01
Website Url:
http://www.readdi.org
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Google Universal Analytics Apache
Current Employees Featured
Official Site Inspections
http://www.readdi.org
- Host name: 118.151.40.45.host.secureserver.net
- IP address: 45.40.151.118
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "READDI"
Who We Are - READDI
READDI’s mission is to provide effective antivirals to everyone who needs them, when they need them, where they need them. READDI was inspired by a prominent team of the world’s …See details»
Why READDI Inc.? - READDI
Oct 16, 2023 READDI Inc. is positioning itself as a core implementor to coordinate all the potentially disparate programs under the auspices of a single, trusted nonprofit. READDI Inc.’s …See details»
Who We Are - READDI-AC
READDI-AC adopts the open science approach of the Structural Genomics Consortium (SGC) for our early-stage discovery campaigns. READDI-AC shares data on our validated hits with …See details»
Our Approach - READDI
READDI, Inc. is an Associated Entity of the University of North Carolina at Chapel Hill. ...See details»
READDI - LinkedIn
READDI CEO James Rosen and Center for Emerging Virus Research Director Dr. Joo-Yeon Lee signed a letter of intention in Osong, Korea, on Feb. 28. Traveling with Jimmy were READDI Co-founders and ...See details»
Why READDI Inc.? - UNC Gillings School of Global …
November 13, 2023. Given that READDI’s Antiviral Drug Discovery (AViDD) Center (READDI-AC) already has raised more than $130 million from the National Institutes of Health (NIH), the North Carolina General Assembly, RTI …See details»
Open Science Drug Discovery Partnership, READDI, Aims to Invest …
Apr 8, 2020 Open Science Drug Discovery Partnership, READDI, Aims to Invest $125 Million to Prevent Future Pandemics. April 8, 2020. By Mark Derewicz. The Rapidly Emerging Antiviral …See details»
Symposium underscores READDI’s role in ‘marathon of …
By READDI, September 27, 2023 — Imagine a scenario where COVID-19 had hit, but the world was ready with a medication that could stop it in its tracks. Making that scenario a reality was …See details»
Symposium underscores READDI’s role in ‘marathon of …
Sep 27, 2023 A nonprofit organization, READDI leverages the latest virology know-how and medicinal chemistry to develop broad-acting small molecule antiviral therapeutics — pills that can be taken with a drink of water — to …See details»
Open Science Drug Discovery Partnership, READDI, …
Apr 15, 2020 The Structural Genomics Consortium (SGC), the University of North Carolina at Chapel Hill and the Eshelman Institute for Innovation announced the launch of the Rapidly Emerging Antiviral Drug Development …See details»
Open science drug discovery partnership, READDI, aims to invest …
April 14, 2020. The Structural Genomics Consortium (SGC), the University of North Carolina at Chapel Hill and the Eshelman Institute for Innovation have announced the launch of the …See details»
Partners - READDI
DNDi has provided READDI with a proven model, given its own approach to nonprofit drug research. Founded by Médecins Sans Frontières, the World Health Organization and five …See details»
Overview - READDI-AC
The READDI-AC Strategy ~630,000 Screened. Primary Screening: High throughput, DNA-encoded library, and fragment-based screens are used to identify novel chemical starting …See details»
READDI Moves From Idea to the Global Stage - Eshelman Innovation
Apr 1, 2024 READDI needed to be a global public-private effort. What Moorman originally envisioned as a spin-out company truly was a moonshot. Nat Moorman, Ph.D. 600 pitch …See details»
Home - READDI-AC
Dec 12, 2024 01.15.25 Drug discovery efforts are producing promising antiviral compounds and academic innovation is the key More; 12.12.24 Antiviral Researchers at University of North …See details»
Public health experts put out call for collaboration in ... - READDI
Aug 30, 2024 However, among the World Health Organization’s priority pathogen families with pandemic potential, there are only approved therapeutics available for COVID-19 and Ebola …See details»
Open science drug discovery partnership, READDI, aims to invest …
Apr 16, 2020 READDI, located in Chapel Hill, N.C., is a non-profit drug research and development (R&D) organization that will focus on the viral families that cause the majority of …See details»
UNC Team READDI for Next Outbreak - UNC Research
Apr 23, 2020 That’s the mission of the recently launched Rapidly Emerging Antiviral Drug Development Initiative (READDI), an open-science, nonprofit drug research and development …See details»
READDI for the Future - University of North Carolina at Chapel Hill
Apr 15, 2020 The science behind READDI is based on a collaborative research project more than a year in the making that received seed funding from the Eshelman Institute for …See details»
READDI, not reactive | UNC-Chapel Hill
Feb 1, 2021 When the World Health Organization declared SARS-CoV-2 a global pandemic in March of 2020, people were not only unprepared but shocked. Carolina researchers Ralph …See details»